Strengthening the DOTS Strategy and Improving the National Tuberculosis Programme (NTP), including Multidrug Resistant and Infection Control, in Bosnia and Herzegovina (BiH)

Function of the project

 Opening of reconstructed laboratories for diagnosis of tuberculosisOpening of reconstructed laboratories for diagnosis of tuberculosis

About one third of the world’s population is infected with tuberculosis (TB) bacteria, however only a small proportion of those infected will become sick with TB. Up to 20 million lives have been saved since 1995 through the DOTS (Directly Observed Treatment Short-course) and the Stop TB Strategies. Bosnia and Herzegovina is categorised as having an “intermediate” TB burden, with approximately 1,400 new cases reported annually over the last few years and a TB-related mortality rate of 6.8%. The majority of TB patients in BiH can be cured with TB drugs as part of the standard treatment course, and resistance to those drugs is rare. BiH has excellent treatment success results with more than 90% of reported TB patients cured. Therefore, it is quite probable that the Millennium Development Goal of reversing the tuberculosis epidemic by 2015 will be achieved in BiH. The United Nations Development Programme project is working towards ensuring access to diagnosis, treatment and care for all people affected by TB, and to eradicate TB once and for all. 

What we do

The targets under this project are:

  • Ensuring the establishment of Health Care Management Units dealing with TB at all administrative levels across the country;
  • Improving the medical infrastructure surrounding TB, and improving patient access to the most up-to-date treatment, by procuring of essential lab equipment for diagnostics and ensuring adherence to safety and quality standards on the part of the medical professionals;
  • Supporting the implementation of infection control policies focusing on timely diagnosis and appropriate treatment of particular drug-resistant strains of TB;
  • Strengthening the health system to provide adequate health care for the most vulnerable and marginalised groups in BiH society, such as the Roma population. This track is reinforced by the establishment of an inclusive TB community care system, and by efforts from other NGOs who aim to enhance health care access through the promotion of communication and social mobility.

Success thus far

 Opening of reconstructed laboratories for diagnosis of tuberculosisOpening of reconstructed laboratories for diagnosis of tuberculosis
  • Tuberculosis cases declined from 2,373 in 2007 to 1,190 in 2014;
  • There has been an uninterrupted supply of TB drugs for all patients free of charge;
  • An integrated, communicative countrywide lab network containing a comprehensive recording and reporting system has resulted in improved TB case detection.

Goals moving forward

UNDP BiH, as a Principal Recipient for the Global Fund to Fight TB, HIV/AIDS and Malaria (GFATM), continues to seek ways to cost-effectively reduce the burden of TB in BiH. The key principle of the project is the active participation of the major health institutions in meeting these goals. The expected final outcomes are: continued high quality and easily accessible TB treatment, ensured sustenance of biosafety for all patients, a connective network of laboratories that are up to European standard, and reliable monitoring, evaluating and reporting practises therein.

Financial contributors





$ 854,148.77



$ 5,864,149.95



$ 3,591,848.95

GFATM $ 3,965,828.36
GFATM $ 905,977.00

*The Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM)

Delivery in the previous fiscal years

2014    $ 2,161,679.00
2013    $ 5,367,642.00


   $ 3,527,949.53


   $ 3,051,209.37


   $ 938,884.00

Geographic coverage

Video about Fight against Tuberculosis in Bosnia and Herzegovina


UNDP Around the world

You are at UNDP Bosnia and Herzegovina 
Go to UNDP Global